Replies to post #666130 on NorthWest Biotherapeutics Inc (NWBO)

[dstock07734]

You are still here. Have you digested the posts I specifically addressed to you before? Now refresh your memory.

Collaboration between Merck and Nano String

https://www.drugdiscoverynews.com/merck-teams-up-with-nanostring-to-develop-gene-expression-assay-9596
https://www.genomeweb.com/molecular-diagnostics/nanostring-merck-discuss-progress-immuno-oncology-cdx-collaboration
https://investors.nanostring.com/news/news-details/2016/NanoString-Technologies-and-Merck-Expand-Collaboration-to-Develop-and-Commercialize-Novel-Diagnostic-Test-to-Predict-Response-to-KEYTRUDA-pembrolizumab/default.aspx

Collaboration between Merck and Illumina
https://www.illumina.com/

https://www.illumina.com/company/news-center/press-releases/2021/d9aab782-eeed-46df-9654-eb1f3b045dd6.html

Timeline on events related to Merck

A high-caliber Merck executive, Susan Shiff joined Ontada, an affiliate of Mckesson, as president in March 2021.

https://www.mckesson.com/About-McKesson/Newsroom/Press-Releases/2021/Ontada-Appoints-Susan-Shiff-PhD-MBA-President/

In August 2021, Merck signed strategic partnership with Ontada.
https://www.ontada.com/News-Insights/Ontada-Signs-Strategic-Agreement/

In November 2021, Merck had massive expansion of vaccine manufacturing facility at West Campus.
https://www.uppergwynedd.org/sites/g/files/vyhlif1351/f/uploads/merck_63a_ld.pdf

In June 2022, McKesson and HCA Healthcare which have the network of community-based hospitals decided to form a joint venture.
https://investor.hcahealthcare.com/news/news-details/2022/McKesson-and-HCA-Healthcare-Announce-Plans-to-Form-an-Oncology-Research-Joint-Venture-to-Advance-Cancer-Care-and-Increase-Access-to-Oncology-Clinical-Research/default.aspx

In May 2023, Dr. Vivek Subbiah who had close collaboration on DCVax-L research with NWBO joined Sarah Cannon Research Institute (SCRI), the research arm of HCA Healthcare's Cancer Institute
https://sarahcannon.com/about/newsroom/vivek-subbiah-md-joins-scri-to-advance-early-phase-clinical-research

In August 2023, a joint vecture by McKesson and HCA was officially formed and called SCRI.
https://www.healthonecares.com/healthy-living/blog/sarah-cannon-research-institute-and-us-oncology-join-forces-to-improve-patient-care

In September 2023, ARPA-H chose Dallas at which McKesson is located as the Customer Experience hub.
https://www.texastribune.org/2023/09/26/dallas-arpha-h-national-hub/

In October 2023, FDA awarded McKesson $3m contract on RWE.
https://www.mckesson.com/About-McKesson/Newsroom/Press-Releases/2023/FDA-Selects-Ontada-Investigate-Natural-History-Rare-Cancers/